Status:
COMPLETED
Gut Microbiome and Serum Metabolome Alterations in ADHD Patients
Lead Sponsor:
Xijing Hospital
Conditions:
Attention-deficit/Hyperactivity Disorder
Eligibility:
All Genders
6-15 years
Brief Summary
Host-microbe interactions play a key role in brain development and function and in the etiology of neurodevelopmental disorders. Attention-deficit/hyperactivity disorder (ADHD) is a heterogeneous diso...
Eligibility Criteria
Inclusion
- Diagnoses of the children with ADHD were made in Xijing Hospital according to criteria described in the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Children with ADHD had an IQ score above 70.
Exclusion
- Children who had a past history of or were currently affected by neurological diseases, including convulsive disorders or brain damage; or who had any evidence of comorbid psychiatric conditions, such as Tourette's syndrome, IQ below 70, pervasive developmental disorder (autism), bipolar disorder, psychosis, language difficulties or learning disorders (reading disorders, mathematics disorders and disorders of written expression).
Key Trial Info
Start Date :
March 20 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 27 2020
Estimated Enrollment :
207 Patients enrolled
Trial Details
Trial ID
NCT03447223
Start Date
March 20 2018
End Date
May 27 2020
Last Update
August 27 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Pediatrics, Xijing Hospital, the Fourth Military Medical University
Xi'an, Shaanxi, China, 710032